LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 25.79 | 27.76 | 929 | 1605 | 0.5788 | 0.8216 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 27.49 | 27.76 | 14 | 1723 | 0.0081 | -0.1086 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 27.49 | 27.76 | 788 | 1723 | 0.4573 | 0.7538 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 27.49 | 27.76 | 20 | 1723 | 0.0116 | -0.0536 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 27.49 | 27.76 | 942 | 1723 | 0.5467 | 0.8072 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 29.19 | 27.76 | 20 | 1863 | 0.0107 | -0.0526 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 29.19 | 27.76 | 827 | 1863 | 0.4439 | 0.7495 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 29.19 | 27.76 | 23 | 1863 | 0.0123 | -0.0305 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 29.19 | 27.76 | 875 | 1863 | 0.4696 | 0.7658 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 30.90 | 27.76 | 18 | 2032 | 0.0089 | -0.0675 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 30.90 | 27.76 | 745 | 2032 | 0.3666 | 0.7009 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 30.90 | 27.76 | 25 | 2032 | 0.0123 | -0.0168 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 30.90 | 27.76 | 817 | 2032 | 0.4020 | 0.7264 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 32.60 | 27.76 | 30 | 2235 | 0.0134 | 0.0123 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 32.60 | 27.76 | 741 | 2235 | 0.3314 | 0.6799 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 32.60 | 27.76 | 25 | 2235 | 0.0112 | -0.0164 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 32.60 | 27.76 | 895 | 2235 | 0.4003 | 0.7307 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 34.30 | 27.76 | 37 | 2449 | 0.0151 | 0.0455 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 34.30 | 27.76 | 775 | 2449 | 0.3164 | 0.6738 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 34.30 | 27.76 | 38 | 2449 | 0.0155 | 0.0498 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 34.30 | 27.76 | 856 | 2449 | 0.3494 | 0.6997 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 36.01 | 27.76 | 43 | 2662 | 0.0161 | 0.0687 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 36.01 | 27.76 | 873 | 2662 | 0.3278 | 0.6884 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 36.01 | 27.76 | 43 | 2662 | 0.0161 | 0.0687 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 36.01 | 27.76 | 964 | 2662 | 0.3620 | 0.7140 | MN20160318_Q01 | I20 |